Rational design and semisynthesis of betulinic acid analogues as potent topoisomerase inhibitors.

J Nat Prod 2009 Sep;72(9):1643-50

Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA 71201, USA.

Chemical transformation studies were conducted on betulinic acid (1), a common plant-derived lupane-type triterpene. Eleven new rationally designed derivatives of 1 (2-5 and 7-13) were synthesized based on docking studies and tested for their topoisomerase I and IIalpha inhibitory activity. Semisynthetic reactions targeted C-3, C-20, and C-28 in 1. Structures of the new compounds were confirmed by spectroscopic methods (1D and 2D NMR and MS). Compound 9, 3-O-[N-(phenylsulfonyl)carbamoyl-17beta-N-(phenylsulfonyl)amide]betulinic acid, showed 1.5-fold the activity of CPT in a topoisomerase I DNA relaxation assay. Four out of 14 betulinic acid analogues (5, 9, 11, and 12) showed 1.5-fold the activity of etoposide in a topoisomerase II assay. The new analogues exhibited better cytotoxic activities against the human colon cancer cells SW948 and HCT-116 and the breast cancer cell line MDA-MB-231 compared to the parent (1). Betulinic acid (1) is a potential scaffold for the design of new topoisomerase I and IIalpha inhibitors.

Download full-text PDF

Source
http://dx.doi.org/10.1021/np900312uDOI Listing
September 2009
3.798 Impact Factor

Publication Analysis

Top Keywords

betulinic acid
16
topoisomerase iialpha
8
acid analogues
8
15-fold activity
8
topoisomerase
5
acid
5
3-o-[n-phenylsulfonylcarbamoyl-17beta-n-phenylsulfonylamide]betulinic acid
4
nmr compound
4
compound 3-o-[n-phenylsulfonylcarbamoyl-17beta-n-phenylsulfonylamide]betulinic
4
acid 15-fold
4
cpt topoisomerase
4
relaxation assay
4
assay betulinic
4
dna relaxation
4
topoisomerase dna
4
methods nmr
4
activity cpt
4
compounds confirmed
4
semisynthetic reactions
4
reactions targeted
4

Similar Publications